Latest Breaking News On - Jon isaacsohn - Page 1 : comparemela.com

CinRx Pharma Closes Additional $73M Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesJon isaacsohnCinrx pharma

CinCor s hub-and-spoke parent nabs new funding to build its next biotechs

CinCor s hub-and-spoke parent nabs new funding to build its next biotechs
biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.

United statesCinfina pharmaCinphloro pharmaJon isaacsohnCincor pharmaCindome pharmaPuretech healthRoivant sciencesDive briefKaruna therapeuticsApogee therapeuticsBiopharma divePhloro pharma

CinRx Pharma Corrals $73M to Continue Hub and Spoke Model of Startup Formation

CinRx Pharma Corrals $73M to Continue Hub and Spoke Model of Startup Formation
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

United statesCinrx pharmaCincor pharmaBridgebio pharmaJon isaacsohnRoivant sciencesPuretech healthRetromer therapeutics

CinPhloro Pharma, a CinRx Portfolio Company, Dosed First Participant in Phase 2 enviva Study of CIN-103 for Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D)

CinPhloro Pharma, a CinRx Portfolio Company, Dosed First Participant in Phase 2 enviva Study of CIN-103 for Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCinphloro pharmaDarren brennerCinrx pharmaJason westerheideJon isaacsohnCassidy mcclainBusiness developmentPhloro pharmaChief executive officerGastroenterology medicineNorthwestern universityFeinberg school

CinRx Pharma Announces First Participant Dosed in CinDome s Phase 2 Study of Deudomperidone (CIN-102) for the Treatment of Diabetic Gastroparesis

CinRx Pharma Announces First Participant Dosed in CinDome s Phase 2 Study of Deudomperidone (CIN-102) for the Treatment of Diabetic Gastroparesis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCassidy mcclainJason westerheideCindome pharmaCinrx pharmaJon isaacsohnBusiness developmentWall streetDome pharmaChief executive officerDeudomperidone phaseDouble blind treatmentScreening periodLead in period